UAB MetaBio Advisors Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| - |
| 0 |
| 2023 |
|---|
| 0 |
| 0 |
| 11,175 |
| -11,175 |
| -11,175 |
| - |
| - |
| -10,175 |
| 10,887 |
| 0 |
| 712 |
| - |
| -1.07 |
| - |
| - |
| - |
| -4,990 |
| 2024 |
|---|
| 45,000 |
| 23,560 |
| 58,695 |
| -58,695 |
| -30,730 |
| -80.66 |
| -130.43 |
| -68,870 |
| 78,770 |
| 1,596 |
| 8,304 |
| 0.11 |
| -1.14 |
| -79.57 |
| -35,808 |
| -80.66 |
| -36,296 |
| 2024 |
|---|
| 45,000 |
| 23,560 |
| 58,695 |
| -58,695 |
| -30,730 |
| -80.66 |
| -130.43 |
| -68,870 |
| 78,770 |
| 1,596 |
| 8,304 |
| 0.11 |
| -1.14 |
| -79.57 |
| -35,808 |
| -80.66 |
| -36,296 |
Turnover (€)
2024
Turnover (€)
45,000 €- *
Sales per employee (€)
23,560 €- *
Profit before tax (€)
58,695 €425 % *
Net Profit (€)
-58,695 €-425 % *
Profit per employee (€)
-30,730 €-175 % *
Total profitability (%)
-80.66 %- *
Net profitability (%)
-130.43 %- *
Equity (€)
-68,870 €-577 % *
Amounts Payable And Liabilities (€)
78,770 €624 % *
Non-current Assets (€)
1,596 €- *
CurrentAssets (€)
8,304 €1,066 % *
Working capital requirement
0.11 - *
Debt-to-equity ratio
-1.14 -6.54 % *
EBITDA margin (%)
-79.57 %- *
EBITDA (€)
-35,808 €- *
EBIT margin (%)
-80.66 %- *
EBIT (€)
-36,296 €-627 % *
